Home/Filings/5/0001140361-11-012560
5//SEC Filing

Rappaport Hanoch 5

Accession 0001140361-11-012560

CIK 0001451980other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 2:25 PM ET

Size

5.2 KB

Accession

0001140361-11-012560

Insider Transaction Report

Form 5
Period: 2010-12-31
Transactions
  • Purchase

    Common Stock

    2010-11-21+17,79617,796 total
Footnotes (1)
  • [F1]The average purchase price was 2.84 NIS per share.

Documents

1 file

Issuer

BIOCANCELL THERAPEUTICS INC.

CIK 0001451980

Entity typeother

Related Parties

1
  • filerCIK 0001466920

Filing Metadata

Form type
5
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 2:25 PM ET
Size
5.2 KB